HIGHLIGHTS
- What: This research aimed to examine the role of_[68 Ga]Ga-Pentixafor PET, PET/CT, and PET/MRI in evaluating LPDs.
- Who: Maryam Zamanian and colleagues from the Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Nuclear Medicine Department, University of Brescia, Brescia, Italy have published the paper: The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review, in the Journal: (JOURNAL)
- How: The authors conducted a comprehensive investigation to explore the pathological expression of the CXCR4 receptor in lymphoproliferative disorders (LPDs) using GaPentixafor PET . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.